IL17A and myocardial ischemia: At the same time, studies have also confirmed that anti-IL-17A monoclonal neutralizing antibody treatment or IL-17A knockout significantly reduced neutrophil infiltration and inhibited cardiomyocyte apoptosis, significantly improving myocardial ischemia-re-perfusion injury.